NCT01581684 - Safety Tolerability and Pharmacokinetic of BI 411034 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2012

Primary Completion Date

August 1, 2012

Study Completion Date

August 1, 2012

Conditions

Healthy

Interventions

DRUG

BI 411034

Low dose solution for oral administration

DRUG

Placebo

Solution for oral administration

DRUG

BI 411034

Medium dose solution for oral administration

DRUG

BI 411034

Low dose solution for oral administration

DRUG

BI 411034

High dose solution for oral administration

DRUG

BI 411034

High dose solution for oral administration

DRUG

BI 411034

Medium dose solution for oral administration

DRUG

BI 411034

High dose solution for oral administration

DRUG

BI 411034

Medium dose solution for oral administration

Trial Locations (1)

1308.1.1 Boehringer Ingelheim Investigational Site, Ingelheim